Beijing Aosaikang Pharmaceutical Co Ltd 002755.SZ

Last Updated: May 15, 12:00 AM·SZSE

Beijing Aosaikang Pharmaceutical Co Ltd

Beijing Aosaikang Pharmaceutical Co Ltd. Stock Analysis 002755.SZ

China Health Care Mid Cap
Beijing Aosaikang Pharmaceutical Co., Ltd. is engages in the research, development, production and sale of drugs. The company is headquartered in Nanjing, Jiangsu and currently employs 799 full-time employees. The company went IPO on 2015-05-15. The Company’s therapeutic areas mainly include gastrointestinal, anti-tumor, anti-infection and chronic diseases. The Company’s gastrointestinal drugs mainly include Aoxikang and Aolirui. Anti-tumor drugs mainly include Aoyixin and Aofuning. Anti-infection drugs mainly include Aotijia and Aidu’ao. Chronic disease drugs mainly include Aoxinyi and Aobeiyi.
Read More
Lock image
crown-icon

Shariah Compliance Report

An extensive business and financial screening of the company which specifies why a stock is halal or haram!

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.